Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net income $ 2,702,697 $ 2,516,662
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 310,300 262,496
Loss on extinguishment of debt 13,286 0
Unrealized foreign exchange (gain) loss and other (35,427) 14,669
Asset impairment charges 9,905 5,962
Disposal of non-controlling interest 8,270 0
Stock-based compensation expense 121,517 90,069
Gain on sale of business (29,687) 0
Deferred income taxes (321,712) (382,975)
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:    
Accounts receivable (153,630) (318,271)
Inventories (604,393) (396,403)
Other assets (30,427) (23,729)
Accounts payable (38,817) 82,376
Deferred system revenue 32,822 141,122
Deferred service revenue 35,551 81,216
Other liabilities 690,435 420,279
Net cash provided by operating activities 2,710,690 2,493,473
Cash flows from investing activities:    
Net proceeds from sale of business 75,358 0
Business acquisitions, net of cash acquired (27,144) (470,887)
Capital expenditures (262,908) (234,160)
Purchases of available-for-sale securities (960,837) (733,386)
Proceeds from sale of available-for-sale securities 74,541 67,505
Proceeds from maturity of available-for-sale securities 699,363 524,677
Purchases of trading securities (77,759) (101,342)
Proceeds from sale of trading securities 70,279 95,734
Proceeds from other investments 1,020 795
Net cash used in investing activities (408,087) (851,064)
Cash flows from financing activities:    
Payment of debt issuance costs (6,515) 0
Proceeds from revolving credit facility 300,000 600,000
Repayment of debt (1,087,250) (345,000)
Common stock repurchases (923,039) (1,394,217)
Payment of dividends to stockholders (553,046) (480,926)
Issuance of common stock 33,908 36,912
Tax withholding payments related to vested and released restricted stock units (73,704) (68,948)
Contingent consideration payable and other, net (5,027) (1,100)
Purchase of non-controlling interest (4,295) 0
Net cash used in financing activities (2,318,968) (1,653,279)
Effect of exchange rate changes on cash and cash equivalents (30) (8,568)
Net decrease in cash and cash equivalents (16,395) (19,438)
Cash and cash equivalents at beginning of period 1,584,908 1,434,610
Cash and cash equivalents at end of period 1,568,513 1,415,172
Supplemental cash flow disclosures:    
Income taxes paid, net 451,243 355,176
Interest paid 198,906 116,791
Non-cash activities:    
Contingent consideration payable - financing activities (1,849) 15,086
Dividends payable - financing activities 5,856 5,375
Unsettled common stock repurchase - financing activities 15,943 6,000
Accrued purchases of land, property and equipment - investing activities $ 14,390 $ 22,305